Skip to Content
Developmental Therapeutics Program (DTP)
Contact DTP
Show menu
Search this site
Last Updated: 10/26/23

Funding Opportunities

Funding Opportunity Announcements

Title Announcement Number Opening Date Expiration Date Activity Code
Assay development and screening for discovery of chemical probes, drugs or immunomodulators PAR-23-264 Sep 5, 2023 Sep 08, 2026 R01
Advancing the development of tumor site-activated small molecules NOT-CA-21-101 Jan 26, 2022 Jan 08, 2024 R01, R21
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-22-216 Sep 10, 2022 July 2, 2025 R21
Next Generation Chemistry Centers for Fusion Oncoproteins RFA-CA-23-037 Oct 15, 2023 Nov 16, 2023 UM1

DCTD Funding Opportunity in Translational Research

Title Announcement Number Opening Date Expiration Date Activity Code
NCI Clinical and Translational Exploratory/Developmental Studies PAR-22-216 Sep 10, 2022 July 2, 2025 R21

NIH Parent Announcements

About the Branch Chief

Dr. Sundar Venkatachalam Dr. Sundar Venkatachalam serves as the chief of PTGB. Sundar earned his Ph.D. in Biochemistry from the Ohio State University, where he studied the molecular mechanisms of DNA damage and repair responses induced by polycyclic aromatic hydrocarbons. As a postdoctoral fellow at the Baylor College of Medicine, he analyzed the role of the p53 haploinsufficiency in tumor susceptibility and aging using genetically engineered mouse models. More…